Multiple Myeloma
From the Journals
Novel approach brings hospice-bound MM patient into remission
With the use of next-generation genomic sequencing and a novel triple therapy, a patient who had relapsed after CAR T-cell therapy was brought...
From the Journals
Pivotal trials in blood cancers don’t mirror patient populations
“The results from this study should lead to questions about the generalizability of drug safety and efficacy in populations we serve as medical...
Bloodlines
Bias and other barriers to HSCT access
A view from the world of cellular therapy and hematopoietic stem cell transplantation.
Conference Coverage
Many die waiting for `last-chance’ therapy
Blood cancer patients, especially those with myeloma, face hospice and death while awaiting CAR T-cell therapy.
From the Journals
Fewer transplants for MM with quadruplet therapy?
Findings bode well for quadruple drug therapy in treating newly diagnosed multiple myeloma.
Guidelines
Evidence still lacking that vitamins prevent CVD, cancer: USPSTF
In its final recommendation statement on the subject, the task force does, however, recommend against use of vitamin E and beta-carotene.
Conference Coverage
‘Extremely exciting’ study results guide MM treatment options
New trial data help inform the tailoring of effective treatment approaches for patients with newly diagnosed multiple myeloma (MM).
Conference Coverage
‘Very impressive’ data promise new blood cancer option
Early data from MajesTEC-1 phase 1-2 studies showed high response rates in patients with relapsed or refractory disease.
Feature
Ex–hospital porter a neglected giant of cancer research
An Indian immigrant who once emptied bedpans in a Boston hospital went on to become the “father of chemotherapy.”
From the Journals
Obesity increasing the risk for cancer: It’s complicated
For some cancers it was “very clear that obesity increased the risk ... but for some other cancer types, we either don’t have enough data yet or...
Feature
Repurposed drug could revolutionize stem cell transplantation
Abatacept to prevent for acute graft-versus-host disease is a game changer for patients receiving hematopoietic stem cell transplants who lack...